TrueWealth Advisors LLC Has $401,000 Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

TrueWealth Advisors LLC grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 29.5% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 816 shares of the medical equipment provider’s stock after acquiring an additional 186 shares during the quarter. TrueWealth Advisors LLC’s holdings in Intuitive Surgical were worth $401,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Ullmann Wealth Partners Group LLC boosted its holdings in shares of Intuitive Surgical by 1.6% in the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock valued at $653,000 after buying an additional 21 shares during the last quarter. One Wealth Management Investment & Advisory Services LLC boosted its holdings in shares of Intuitive Surgical by 3.4% in the 2nd quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock valued at $310,000 after buying an additional 23 shares during the last quarter. Daymark Wealth Partners LLC boosted its holdings in shares of Intuitive Surgical by 0.3% in the 3rd quarter. Daymark Wealth Partners LLC now owns 7,027 shares of the medical equipment provider’s stock valued at $3,452,000 after buying an additional 24 shares during the last quarter. Indiana Trust & Investment Management CO boosted its holdings in shares of Intuitive Surgical by 5.3% in the 2nd quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock valued at $222,000 after buying an additional 25 shares during the last quarter. Finally, Hoxton Planning & Management LLC boosted its holdings in shares of Intuitive Surgical by 4.9% in the 2nd quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock valued at $238,000 after buying an additional 25 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, EVP Robert Desantis sold 240 shares of the firm’s stock in a transaction on Monday, August 12th. The stock was sold at an average price of $464.76, for a total value of $111,542.40. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,558,968.56. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, EVP Robert Desantis sold 240 shares of the firm’s stock in a transaction dated Monday, August 12th. The stock was sold at an average price of $464.76, for a total value of $111,542.40. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,558,968.56. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares in the company, valued at approximately $12,391,166.97. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 68,246 shares of company stock worth $33,839,308. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG traded up $2.50 during mid-day trading on Friday, reaching $506.34. The company had a trading volume of 1,041,997 shares, compared to its average volume of 1,277,244. Intuitive Surgical, Inc. has a one year low of $269.49 and a one year high of $523.34. The firm has a market cap of $180.35 billion, a price-to-earnings ratio of 81.41, a PEG ratio of 4.95 and a beta of 1.39. The business’s 50-day simple moving average is $490.41 and its 200 day simple moving average is $447.08.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a report on Friday, October 18th. Royal Bank of Canada increased their price target on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Truist Financial increased their price target on Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a research note on Monday, October 14th. Barclays increased their price target on Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a research note on Thursday, July 18th. Finally, Mizuho increased their price target on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $513.74.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.